AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $146,000 | -24.0% | 67,517 | 0.0% | 0.00% | – |
| Q2 2022 | $192,000 | +40.1% | 67,517 | +106.4% | 0.00% | – |
| Q1 2022 | $137,000 | -19.4% | 32,704 | 0.0% | 0.00% | – |
| Q4 2021 | $170,000 | -10.5% | 32,704 | +12.8% | 0.00% | – |
| Q3 2021 | $190,000 | +33.8% | 28,984 | +35.8% | 0.00% | – |
| Q2 2021 | $142,000 | +125.4% | 21,337 | +95.9% | 0.00% | – |
| Q1 2021 | $63,000 | -35.1% | 10,891 | 0.0% | 0.00% | – |
| Q4 2020 | $97,000 | -3.0% | 10,891 | +25.8% | 0.00% | – |
| Q3 2020 | $100,000 | -27.5% | 8,660 | 0.0% | 0.00% | – |
| Q2 2020 | $138,000 | +411.1% | 8,660 | +87.3% | 0.00% | – |
| Q1 2020 | $27,000 | -41.3% | 4,623 | +31.5% | 0.00% | – |
| Q4 2019 | $46,000 | +2200.0% | 3,515 | +2307.5% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 146 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 146 | +217.4% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,300,000 | $17,160,000 | 2.55% |
| Alphabet Inc. | 699,352 | $9,231,000 | 0.56% |
| DAFNA Capital Management LLC | 100,000 | $1,320,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 705,356 | $9,311,000 | 0.29% |
| Artal Group S.A. | 500,000 | $6,600,000 | 0.26% |
| Cormorant Asset Management, LP | 479,988 | $6,336,000 | 0.25% |
| MPM BioImpact LLC | 39,740 | $525,000 | 0.19% |
| Granahan Investment Management | 305,158 | $4,028,000 | 0.18% |
| Burrage Capital Management LLC | 13,113 | $173,000 | 0.12% |
| Vident Investment Advisory, LLC | 118,866 | $1,569,000 | 0.10% |